Loading stock data…
$38.09+1.27 (+3.46%)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.
Phibro Animal Health Corporation in the Healthcare sector is trading at $38.09 with a market capitalization of $1.6B. Wall Street consensus targets $44.00 (4 analysts), implying a +15.5% move over the next 12 months. The stock is currently 37% below its 52-week high of $60.08, remaining 7.2% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: RSI 72 is overbought against a weak tape. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $396.75M↑ | $383.54M↑ | $373.91M↑ | $363.89M↓ | $378.70M |
| Gross Profit | $134.40M↑ | $125.67M↓ | $132.66M↑ | $119.78M↑ | $110.01M |
| Operating Income | $48.16M↑ | $44.65M↓ | $50.33M↓ | $51.26M↑ | $33.72M |
| Net Income | $21.71M↓ | $24.02M↓ | $27.46M↑ | $26.53M↑ | $17.22M |
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mine...